drugset / Trial / NCT03963102
Duration of Ameluz Application in Acral Actinic Keratoses Response
RandomizedParallel-groupSingle-blindTreatment
Summary
A phase IV study of a single topical application of ALA for 3 hours or 4 hours to AK on acral sites (hands, feet, arms and legs), and subsequent measurement of clinical efficacy with corresponding PpIX fluorescence imaging.
Timeline
- Start
- 2019-10-30
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | — | Topical |